These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31440977)

  • 1. Seeking clarity: Insights from a highly effective preparation protocol for suppressing myocardial glucose uptake for PET imaging of cardiac inflammation.
    Osborne MT; Divakaran S
    J Nucl Cardiol; 2020 Jun; 27(3):862-864. PubMed ID: 31440977
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquisition, Processing, and Interpretation of PET
    Celiker-Guler E; Ruddy TD; Wells RG
    Curr Cardiol Rep; 2021 Jul; 23(9):124. PubMed ID: 34269917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
    J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
    J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.
    Scholtens AM; Verberne HJ; Budde RP; Lam MG
    J Nucl Med; 2016 Apr; 57(4):568-73. PubMed ID: 26659348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a highly effective preparation for suppression of myocardial glucose utilization.
    Larson SR; Pieper JA; Hulten EA; Ficaro EP; Corbett JR; Murthy VL; Weinberg RL
    J Nucl Cardiol; 2020 Jun; 27(3):849-861. PubMed ID: 31236832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
    Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
    J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of post-myocardial infarction inflammation evaluated by
    Xi XY; Zhang F; Wang J; Gao W; Tian Y; Xu H; Xu M; Wang Y; Yang MF
    J Nucl Cardiol; 2020 Apr; 27(2):519-531. PubMed ID: 31741330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging.
    Bulluck H; White SK; Fröhlich GM; Casson SG; O'Meara C; Newton A; Nicholas J; Weale P; Wan SM; Sirker A; Moon JC; Yellon DM; Groves A; Menezes L; Hausenloy DJ
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):e003900. PubMed ID: 26926269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET Imaging of Post-infarct Myocardial Inflammation.
    Ćorović A; Nus M; Mallat Z; Rudd JHF; Tarkin JM
    Curr Cardiol Rep; 2021 Jul; 23(8):99. PubMed ID: 34196824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography: evaluation in a porcine model of myocardial infarction.
    Lautamäki R; Schuleri KH; Sasano T; Javadi MS; Youssef A; Merrill J; Nekolla SG; Abraham MR; Lardo AC; Bengel FM
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):299-305. PubMed ID: 19808610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
    Osborne MT; Hulten EA; Murthy VL; Skali H; Taqueti VR; Dorbala S; DiCarli MF; Blankstein R
    J Nucl Cardiol; 2017 Feb; 24(1):86-99. PubMed ID: 27277502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Likely Common Role of Hypoxia in Driving
    Yao Y; Li YM; He ZX; Civelek AC; Li XF
    Cancer Biother Radiopharm; 2021 Oct; 36(8):624-631. PubMed ID: 34375126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression on
    Osborne MT; Qamar I; Selvaraj S
    J Nucl Cardiol; 2023 Jun; 30(3):938-940. PubMed ID: 36694034
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel dietary protocol prior to 18F-fluorodeoxyglucose positron emission tomography to evaluate for cardiac sarcoidosis.
    Hutt E; Jaber WA; Jellis C; Mountis MM; Cremer PC
    J Nucl Cardiol; 2021 Oct; 28(5):2190-2193. PubMed ID: 33051803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction.
    Vasudevan P; Gaebel R; Doering P; Mueller P; Lemcke H; Stenzel J; Lindner T; Kurth J; Steinhoff G; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of inflammation.
    Buscombe J
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):284-9. PubMed ID: 25265249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.